
Drug-Free Nasal Spray LUCA V-Defense Creates a Protective Shield Against Viruses and Allergies
SEOUL, South Korea, June 27, 2025 /PRNewswire/ -- As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, non-pharmaceutical prevention options is growing. South Korea–based biotech firm LUCA AICELL has developed LUCA V-Defense Nasal Spray, a drug-free nasal spray designed to form a protective barrier on the nasal lining—offering a modern solution in the post-mask era.
A Physical Barrier, Not a Medication
Unlike traditional nasal sprays that rely on steroids or antihistamines, LUCA V-Defense forms a non-medicated barrier across the nasal mucosa, the body's first line of defense against airborne pathogens. Instead of using steroids, antihistamines, or vasoconstrictors, LUCA V-Defense relies on lambda carrageenan, a natural compound extracted from red algae, and antimicrobial lipids. These ingredients coat the nasal lining, helping to prevent viruses like SARS-CoV-2 and influenza from binding to mucosal cells. Recent studies have also shown that lambda carrageenan not only possesses antiviral properties but also exhibits anti-inflammatory and anti-allergic effects, helping to reduce allergic reactions in nasal tissues and inhibit histamine release, which may contribute to the prevention of allergic rhinitis.
Using LUCA's proprietary lipid nanocoating technology, the nasal spray demonstrated 99.7% antiviral efficacy within one minute in an in vitro third-party COVID-19 lab study overseas. This suggests potential across a broad spectrum of respiratory viruses.
Rapid Adoption and International Certifications
LUCA AICELL reports that sales of LUCA V-Defense more than tripled in the most recent quarter, signaling increasing consumer interest in preventive nasal sprays. This demand is especially strong among parents and travelers, given that no vaccine currently exists for Mycoplasma pneumonia, a common threat to children.
LUCA V-Defense is classified as a medical device, not a pharmaceutical. It holds:
These credentials validate its safety for daily use and its alignment with international regulatory standards.
Safer than Steroid and Decongestant Sprays
Many popular nasal congestion sprays contain steroids or vasoconstrictors like methazoline, which can offer fast symptom relief but are linked to rebound congestion, mucosal thinning, and reduced efficacy with long-term use.
LUCA V-Defense addresses these issues with a plant-based, non-pharmaceutical formulation that's free from steroids, antihistamines, and methazoline. It is gentle enough for children, pregnant women, and individuals who suffer from seasonal allergies or chronic rhinitis. Its ease of use, a simple mist inside each nostril, makes it ideal for travel, commutes, or high-exposure environments like offices, schools, or public transit.
As the world transitions away from masks and into a new phase of pandemic management, personal preventive tools like LUCA V-Defense are gaining relevance. Whether navigating crowded airports, allergy season, or cold and flu outbreaks, this daily-use nasal spray offers a chemical-free alternative for respiratory defense.
"The pandemic changed how we think about personal protection," said a LUCA AICELL spokesperson. "LUCA V-Defense was developed not just for short-term response, but for long-term respiratory wellness. We see it as a smart, science-backed addition to modern health routines."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Korea Herald
15 hours ago
- Korea Herald
Health minister nominee Jung Eun-kyeong, disease specialist who spearheaded battle against COVID-19
Jung Eun-kyeong, President Lee Jae-myung's pick to head the Ministry of Health and Welfare, earned nationwide fame during her tenure as the inaugural commissioner of the Korea Disease Control and Prevention Agency. The 60-year-old was at the forefront of the nation's response to the COVID-19 pandemic, and headed the KDCA as a vice minister-level official from September of 2020 to May 2022. She joined Lee's presidential campaign this year, ahead of the June 3 presidential election. She had risen through the ranks of the KDCA's forerunner National Institute of Health since joining in 1955, then through the KDCA as an expert in disease control. If her appointment to the minister post is confirmed, it would be the first time since 2017 that a medical doctor would be heading the Health Ministry. One of her tasks as the new Health Minister would be to resolve the ongoing confrontation between the government and the medical circles, which has been going on since February of last year when trainee doctors across the country engaged in a mass walkout.

Korea Herald
a day ago
- Korea Herald
ESOT Congress 2025: Scientists create functional human islets in 3D printing breakthrough for type 1 diabetes treatment
LONDON, June 29, 2025 /PRNewswire/ -- A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional human islets using a novel bioink. Presented today at the ESOT Congress 2025, the new technology could pave the way for more effective and less invasive treatment for people living with type 1 diabetes. The breakthrough involved printing human islets – the insulin-producing clusters of cells in the pancreas – using a customised bioink made from alginate and decellularised human pancreatic tissue. This approach produced durable, high-density islet structures that remained alive and functional for up to three weeks, maintaining strong insulin responses to glucose and showing real potential for future clinical use. Traditional islet transplants are typically infused into the liver, a process that can result in significant loss of cells and limited long-term success. In contrast, the 3D-printed islets were designed to be implanted just under the skin, a simple procedure requiring only local anaesthesia and a small incision. This minimally invasive approach could offer a safer and more comfortable option for patients. "Our goal was to recreate the natural environment of the pancreas so that transplanted cells would survive and function better," explained lead author Dr. Quentin Perrier. "We used a special bioink that mimics the support structure of the pancreas, giving islets the oxygen and nutrients they need to thrive." The bioprinted islets stayed alive and healthy, with over 90% cell survival. They responded better to glucose than standard islet preparations, releasing more insulin when it was needed. By day 21, the islets showed a stronger ability to sense and react to blood sugar levels – an important sign that they could work well after being implanted. The constructs maintained their structure without clumping or breaking down, overcoming a common hurdle in earlier approaches. Additionally, the 3D-printed structures featured a porous architecture that enhanced the flow of oxygen and nutrients to the embedded islets. This design helped maintain cell health and promoted vascularisation, both of which are critical for long-term survival and function after transplantation. "This is one of the first studies to use real human islets instead of animal cells in bioprinting, and the results are incredibly promising," noted Dr. Perrier. "We're getting closer to creating an off-the-shelf treatment for diabetes that could one day eliminate the need for insulin injections."


Korea Herald
3 days ago
- Korea Herald
Ph fintech GCash unlocks insurance for 14 million Filipinos
MANILA, Philippines, June 27, 2025 /PRNewswire/ -- Insurance has traditionally been perceived as a luxury for many Filipinos, often sidelined due to daily financial priorities. GCash, the country's leading finance super app, is changing this through its digital insurance platform, GInsure. Launched in 2021, GInsure offers flexible, straightforward, and affordable coverage and is conveniently available on a platform trusted by millions. As of the first quarter of 2025, GInsure has unlocked insurance for over 14.6 million users, issuing more than 51.4 million policies. "We are humbled to be able to come to the aid of users who are looking for a more affordable and accessible way to protect themselves and their loved ones," said Winsley Bangit, GCash VP and Head of New Businesses. Focusing on affordability, GCash enables more Filipinos to build financial resilience. Users can select from over 48 insurance products in the app's Marketplace, covering Health, Life, Travel, and more, underwritten by GCash's partners. Protection can also be enhanced when transacting online. For instance, "Express Send Scam Insurance" provides personal cyber protection for just Php30 for 30 days. More recently, GInsure introduced "Buy Load Plus Health Insurance", offering free health and accident insurance to customers purchasing mobile load credits via the GCash app. Eligible users can receive up to Php 30,000 in free accident and health insurance benefits, including hospital income coverage of Php 500 per day for up to 5 days if unable to work at no additional cost. For GCash, micro-insurance is a practical way to extend financial protection to those traditionally uninsured or under-insured, addressing communities with the greatest need but limited access to conventional products. This initiative helps make financial protection a realistic part of everyday life for millions of Filipinos. For more details, visit